ArticlePlant cell reports2026
Comparative physiological, hormonal, and transcriptional analyses reveal the difference between diploid and autotetraploid rice under cadmium stress.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
key messageElevated cadmium (Cd) stress tolerance in autotetraploid rice at the seedling stage is correlated with coordinated remodeling of ROS homeostasis, hormone signaling and transcriptional programs. Polyploid plants commonly exhibit robust tolerance to various abiotic stresses, while the underlying regulatory mechanisms remain largely elusive. To elucidate the intrinsic mechanisms underlying enhanced Cd stress tolerance in autotetraploid rice, two pairs of diploid (2X) rice and their corresponding autotetraploid (4X) lines were used as experimental materials for Cd stress treatment and systematic phenotypic, physiological, and molecular evaluation at the seedling stage. Phenotypic observations confirmed that autotetraploid rice displayed markedly stronger Cd stress tolerance than diploid rice, as reflected by approximately 1.5-fold greater plant height alongside elevated biomass and chlorophyll content. Physiological and biochemical assays revealed that autotetraploids exhibited markedly lower Cd content, higher levels of soluble sugars and proline, distinctly lower levels of ROS-related indicators (MDA and H₂O₂), and markedly elevated activities of antioxidant enzymes (catalase, CAT; peroxidase, POD). Comparative phytohormone quantification demonstrated that autotetraploid rice had significantly higher levels of tryptamine (TAM), indole-3-acetic acid (IAA), indole-3-acetyl-L-aspartic acid (IAA-Asp), jasmonic acid (JA), jasmonoyl-L-isoleucine (JA-Ile), and gibberellins A₁ (GA₁) and A₇ (GA₇) but significantly lower levels of cis- (cZ) and trans-zeatin (tZ), with about 2.6, 1.3, 2.3, 1.4, 2.0, 2.6, 2.1, 0.5, 0.6 folds of diploid plants, respectively. Transcriptome profiling revealed that under control conditions, the number of differentially expressed genes (DEGs) between autotetraploid and diploid was merely 939 in roots and 313 in shoots. Under Cd stress, however, the counts of DEGs markedly increased to 4974 in roots and 1023 in shoots. Notably, genes involved in heavy metal transport, and hormone and ROS metabolism were significantly enriched in autotetraploids. Furthermore, qRT-PCR validated consistent expression trends of core metal transporters, hormone biosynthesis genes, and antioxidant genes between the RNA-seq data and independent samples. Collectively, this study suggests that the distinct regulations of physiological and biochemical processes, hormone metabolism, and transcription in autotetraploids under Cd stress are correlated with their enhanced Cd stress tolerance.
Indexed as
Identifiers
42763836What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.